Usenaadainewunnuenssun iso wsuAe Gos anaravowangruuanstoyaqunw Usvavdnw uazavivaonivvasetlunrseiony Tudraiqynastunadoudiuer uazwdninustuardoulvlunrsiersuitoyamuqanm Usa uazaraonewow Ulelinisvedaorquarmsoygnalidangludmqmstunsidowhiuendululaedaqu wanvaunamdnnims uaendamamatamaananaes orfudnunemumrailute a (a) uate of asandowussngnsensranrslooyludamynsty yevioutriuen 1A, bed iaminrsnuensaimsomnsuaveasoonvsemAld Mvialuil do o User nil Mliverutuue Tudewintuusemelusrafeanyunw dual Yo © tonarsvfovdng muanstoyaqaun UsvavBnw uasrraaonievedlunrsdaary Judrfymsduneneusrduer Widulumaenaruuutreusen red fo os lumsiierseaurdoyaduqunm Usedvdew uavaruaonstevowuionsoyqin VWirdoorgludtqarstuneideusaduen Widuldmundninasivaztouly samanarsuuurie usennald sad Wd & vsema a fut bot fuerew WA ee Or finelwmn tury manquenssunrorwruncensensrsuuuireusenaditinsuAuenssunise MAUNA Gos tonaravfowdngudastoyaqunm Usavdnm unzavuvaoniuvewlunrsviony Tudrignastunadeudiues usendninastuardoulvlunrsiiorsntoyadauqann ‘UssvBaw uasariuusanivvew aviudl bed fueron we. eos souil o wonarsvfondingrmanstoyaqaunm Uscndain uacraaondvvoserlunsrioary dae Judhaymstunerdourriuer @. one avfondng udhniunatourunuilegdudmiuanyed vonarisvonding na uqaun tonenaiieattudaendaey ~ renerauanetarmunnmaguvastaendmquavisiunaent + mitdoiusowamsbanevie dy o.0. tonarsiiearuendisegu ~ tonarsuansqasdauusenou dunounrswanuaemsnauqunisHan todamun anasgruvasdaulsenouiibailadrund iy dorhmunnmsgmvowmantanidulaguuaisias ey way snuaxumisnrainwuarnNUNTainwAT ALAN - nbsdofurosmanstnsrwsiednstaunidsagu ~ enansvdondngiuatluayunsusuvaougasdquusenou Sshinseviildiamenys Uluaduumaerlaidrdy ovo tonmnaviondingrudauuseanarmuagaraaonsi 0.6 1oNa17 Summary of Product Characteristics (SmPC) avfutlogiuvaswmAnAeusievininy msduseavasosAnrsawilelan (WHO prequalification program) wiewaesuAruAuEiiisevU nisthituquatJuvivendu (Stringent Regulatory Authorities, SRAs) Wauri annanylsu (European Commission; EMA) avigauiim (the US Food and Drug Administration) shu (the Ministry of Health, Labour and Welfare of Japan /the Pharmaceuticals and Medical Devices Agency), Aimvotsuaudl (Swissmedic), wawrm (Health Canada), seainsiau (Therapeutic Goods Administration), laduaua (Icelandic Medicines Agency), Liechtenstein uadtad (Norwegian Medicines Agency) uae avaie aimnins (Medicines and Healthcare products Regulatory Agency, MHRA) Tautouiunsideudriu enilitaendiagy quuuu uavmrmusansetuermanenans SmPC Mis aa wie ovo.o vangrunatuelutiyiemdnuinn’ viowadiyusedaiu wie o.oo lunsdithidusmuta 0.0.0 via oo. Wdenenumstenioonasmvinnst ailuayulseavénrnvformanlaanitas on UHUNISTANISATINaIAUAUAIW UsvauBaw Waxariuaony uazdrsusesN1s sridiunrsmanununrsdanrseriandes daviunsdiiitosdarhununrsdanrsar andes wb. ioneiavtondng md infuneiTouenunutlaqdudantuded ve.0 tonenavoningrudmuqsunmn e.0.0 wonmrafienitumanhiy - Forhmunannagnunosiaend aquaitunmet - mide fusomanrstvesesbtaerehye.o.0 tonaraieaiuendasegu - tonarsuanagasdaulsenoy Tunounisnainuaensaununsnae tartmun anaagnuvosdawUsenoumlilisaurdray dort mnumnmsgnowdnlasidusoguacisies wy way snuaniunTimsfineuaenunumsanyarunsan - nbsoFusomanrvesrwsiadinsnuvidasagu ~sonanavfondng umiuayumsusunldougnsdawlsenoy dsbinsevhildiamens Uuivdoumaertaidaaly to. toni nfondngrud usar muasaraaoniie 'olo.@ kone71s Summary of Product Characteristics (SmPC) we Product Information atu daqUuvomnsinusieviunstusesinmausurhuquaendnvouiulumeuseine Vu (o) wausquriuguauivasavninglsy lun European Medicines Agency (EMA), Veterinary Mutual Recognition Index (VMRI) uaz Heads of Medicines Agencies (HMA) (e) niresrurhuguasrvasUseinnansrtorardns lun Veterinary Medicines Directorate (VMD) (on) wUawsruAWuguavasUseimmansgainina Luni U.S. Food and Drug Administration (USFDA) waz United States Department of Agriculture (USDA) (c) mhesutfuguavoslseinrunwin soaenay totuaud uavdhu (e) mherumrtuguasrmosdseinalunduannrnelsy wu losuaud oaainte word av dana ded waidon naisoduaud dam aro rsnigitn uavdamde uly (0) mhusrurtafuquavassemelundsowain ly iiu usta uaedingln udu Tnetouduneidousriueriiivendidgy avmuse quuvy dousld wrnuavténrsld windad uae seuemyaen (nsdluwililudoitamsvaina) ulvemnonarsitidads blole LonarsuansrinUaunnuqaqnuaserivenl¥iandasluciade (Maximum Residue Limit (MRLs) fitfnmunlaemiasst Codex Alimentarius wa European Medicines Agency (EMA) 307 Tolerances firhmusilauyiaua U.S. Food and Drug Administration (USFDA) wa United States Department of Agriculture (USDA) lunsdiuneiieus dus iitludediilansvalanvemyued 6.6.0 lunsiiiitunrmute 20.0 ay lo.b.b Wdsnesunrsderioinarsmsisins vowndndusiomuosiintuayulseaninonnanvaonie om WnUNIsTANIsATINAEAM UMA UsvansnIW uAZATUUAOAAY uazdrsus0NNTS shidiunrsmuaunrsdanisarades diniunsdividosdminuwunisdanvsar ides a. tonshviondngudmdunidousunulusnudniudes a.0 onerramawdng ud uqnunwuaserdisogU - lonansuansniuaeiSunnsatimanfinn uaviormunnnagnesnindeusierdrseguuay Thani - whodusmanstenwinavudoudaaundd ae wonaratondngrumuusyausamuazrravaonie vonanavfandnguusetinrsldonaosinriiediuddumandostarngmsunndunulne viounudu Wun drswresdanugdaay dsadorsarsmsivinasitdituianarsdrds uae FoFnfuornnneddermqorteinsunndunulventoundy viohenarstayamsinermand »arlvayuusvandarmuavaravaondusauiuastarmsdady lnunsidoutsuertosiigns souusenau Fousld unewiindn’ hulumauonarsndnguildssds a.m uMUNadanisATNasMURUAW UszavinIw UazArIUAeAAY uaz suseeNIS shidumsmmununrstansavunies doudunsdiidostaaueunrssanisarandes douil w wéhinnustunsdoululunsiersetoyadunann User uaerraaonsivvew vdninustuartoulslunsiionsantoyad ugar Useavbaqw uaveraoniovowi voriooredtswaniiunded lnvbifiorsanieyartemuntitluduqunw UsvdvBnww uavaraaont vow UsenouMuMMUNdansAaaMuREAIN UseanBnm uavaranndy waxdadusos one 9 wneniverioogtulumamdnienns billdnuuvmusnan ce uvewsesietysae We letao uaewlutlafania uaceniuitusvlomannnihenandes Wifey wilehdsoygnalinooreludarynys dureidoutriuer 0. erunutleqdudrntunyuduncnd o.0 maviansatoyaduqinmn dudninustuardoulvtunsieran dil wonansvdondingm wdhinaustueeioulwlumsieran fortmumnasguvesaenday | sasuansnuanduntarwunany Tmennaou uavincust 25.4.1) Aifiesanlumsveutu adesuiiu ] Bianwvihwrdyiy 3.25.42) | KoseyiianetilinedouserdiAlg munsillunsdide davistudd @. NaF uarevin-wsira12 (compendial methods) ‘Wituuiarnzianana monograph bo. nsilFiiiasevilsidulumadtrsye (i specification) Wiuuuswaxiaunsiaredyniatia a. nserver Wuwurwasdon house Agiunnetyniito wnhdafusowanivieswt Foutumsiusowmamvuey duu @ {unrsvenn (certificate of analysis) vowtaur | GuainTnqiuturdiey uaxiudnndnsiousior winuSaunels ay _ afinmauurtdamossusossinynuntls gaidauusene (3.2.P.1) o, Mowsuidnueeen Asi oo UuvUE uaeanvaiaM eno wansnusie? owe daviadoerse wiawauriould (reconstitution diluent) fuuuantiven (dil) on vinvornmusussquacdDanlidaniundndasion uaedrududarhdoonerlanauriowld (nit) we. dosuanaqnadquuseneu Tnuseyde Uinauazsey mhutaviuwsuartinintuanin souteseymliuas quunwiledrsdsludioqun manag uit Gunounrandmuaemiamuqins | o. Hosuanagnsewaqunrstiaa (Batch Formula) a erry wan (3.2.P.3.2) Mssytoyadeioluidvonanawfowaingru vaninoustunstoulvlunrsiininn og sifounnRanausaerd aay wavarsBu 9 tu gasvioqunrsndin saufleansiitonowantuserantsada Tne seynhutaviinosuacthintuanin aio ensiiioyneiuayuuasinqaves overage om se ytqWaundiedteuste ern sndniaqumanan to, fomanansevaumsnamuaeTénsnauuNieUauNS wan (Manufacturing Process and Process Controls) 6.2.3.3) dssvytoyatetolud bo MadvreumdunudauansnsevIUnrsNaa uae Bnav unre vIuMaAn TneseytunounrsHanuae AnqiulluuiaedreemmevauNs uaeseyhunowuae yadifqyvosn sm ruqunssuruns nenasouaraiduns uaemsnququndnsttusierdsogu bo MosuwTiMaifemuaen sibs neinioves dauusenousiie 9 du arvuvuss9 data udu lunsdl nfiadfoustusinerniiia (sterile product) Jarrmunsnaagaves sawlsenouitaitiaendiy (3.2.P.4,1) Mosuanrwarduntorhimunawwe Tmsnaaou uaxinst Mifiersuntunrsvouty envdu arsuyeusiaurewinitior uanatortunany iu 4 arsusisnau Wuwu certificate of analysis naumula Winnevdruisenoviallan wrdreigy (3.2.P.4.2) 0. NTs swwiguuntusena (compendial methods) Titus monograph vesa1sUqIUAs we. ns HGavwetvondudntbidulumtswa Jgnuntusenin Wuannuasidundsiunneinntate wikdetusowaniinsey (certificate of analysis) v9 douulsenouitlluimaurdaey Foudumadureuamvianiey dum » qunraNainvesaTs Uyaueislurty Sorhrmunsninagruendufogu (3.2.P.5.1) o. Hositiormunamwnosndnstouvieusogutulumudisy eniliguuntusenia iamaaulanangmiy (Regulatory specification) waaiivormunntulumunsdlansdivils aviotud oo Ntiitotmumnasguuitatelidulumadin eniiguuedusenin Wudanmnauasuuundngruatuayu o.e asitiduewendiswiiiguatuseme Wiuds Hort mumnwsgrumantatouuameves ICH Faugsunn Avil ove.o vuedidvdunyed Witter muammuwa ICH Huma Q6A, oes uitaingd wiuiyud Wiltorvuanw | wuawns ICH sauqgunmn Q68vonenavowangns waninostuacitoululunisienan olen wuautleytudiniudnd Wiltermua anmag urd doquuasisiarwimuvatoveuwinn ASEAN vio VICH Guidelines #uqaunin 'o. lunsilifiivor munnosgunrdrdaguuar Biase Tlumsmuquqnmmidtumelgda (dni) Fooutelditu Heyer Wianwvterdausag (3.2.P.5.2) dareyiPianeiilinnaouydrategd munsilunsdinils Aasiolud ©. NIMFBiaswvewstrs101 (compendial methods) ‘Wiuuutamzianans monograph ©. nsill¥astaseviivarsauvosdndn Wuwy swaridunisianeiynato thd Wiaseitasaaandos ffutforamunanimsgrumantatounamrevos ICH Ahuqgunn widoiurewanvianet (certificate of analysis) vest didog Soudumsiusemnamvinmeieangadinndndiurien rau o jumaaaia maesreaouRTngntosves nwitasie (Validation of Analytical Procedures) (3.2.P.5.3) SoquansswaxSuntoyanvsnsreaounruigntosvesis Funsienl desautladoyarinmsnnnord wiv BeiMy nnaoundnusidasegy lunsiivisiaswdfimnwanves gun Toyanrsainerrrunsann (3.2.7.8) o, FOwMANsT WALLSUMTENIsANwUALTUSUATIUALANIN (Stability Data) a1 ASEAN Guideline on Stability Study of Drug Product d>miuauautlegtudintunyyd uavdiniuen uautegiudwivantiiulumuuuans ASEAN wie VICH Treuuuaanisinwianunsanluguuuutinnia iu ors nsw Araduie uaversitioyavorisiltieneviuas minsreaouATgnioworisiasied delunsiiniiioya misainwrnrumsan ma qeilaiuaysA Mulund Uva ASEAN oxuds Widutioyaiuiltuaylnly ». nadineideus Fueridoyanrsainwiarunsanrnds sonndosifuanyunamuunms ASEAN wie VICH ulaiisoxa misfinwuuulis aansnltiaya on-going stability data via annual stability data davdueriiilaviwuasia (stable) laitiow nine qumsniin doufuuniilsinada (unstable) weoqUuvuer iernanausgs (critical dosage form) Laitiouny » qunawn Tnenecdowh fue vititoyamsanwinrunsamnmunryerl ‘Wivowgla aanselitoyatuilttuaginly o. nadiilddutoyan sane inrmesannliudausdslai fhulunnuuamns ASEAN arséutioua on-going stability data «tonanafondngTy waninustuastoulvlumafievan va annual stability data dausuuriilemunsta (stable) Lai tiount & {unisnda dmsuurilrinada (unstable) wio quuuueriinrmiauags (critical dosage form) lhitiaunia qunnsnde uavdostoniunudanrsarmavsisenounwA JusoslunnsinvmunsannaunsuM UE ys? uavseEIA Aunsdenwsnuli ov. nev «, nstiigslaunedutayannsfinwinnunsanrnntoiitoya nisfinwinrunsaamuddelainsumua ger Kosuans siwaxidumisnrsAnw (Stability protocol) uassIwIIUATIN asanrniis accelerated stability > dau wae long term stability odraiow » Wu niawtedavhnendusodlunrsainw arunsann uaedesunuitand abou mnstuuAsuML ony «, nrduidenududumsarsrsquuastianrsa dhudunrsduonarsarunsanmmataeula Wituoanana sonadidy ed ov. cxfiensanrnumnvantbus wns wonervovingualuayums | Aersanoygraniriduduanwdsulsenovilallddae Uiuudougaadaulsenou ang lnutosuanssqwaxidunddauusenovduiarn Uaonsty luvauruitdaonde iu nsd.sdsgiudaya ingredient uv was USFDA wiowhwswauiiduivouty duc oo nisHersartoyaduuseauBarmuazarmuaoady dudninastuasdoulwlunrs fiavsan asi oco.0 neiTouhFuounuilagdudrndunyed Hoyotruseaniamuaceravaondy iivdninasiuactoulvlunrsiionsan ded (o) shdueniiivwwaurdiéy qUUUU uavArmussnsstuealaivoylales SRAs axdosdraBanrsoyslaneifoumuewowseine SRAs oaluayuuseavsaruasar Unandevasuils wazuanssiwasidemves Summary of Product Characteristics Aududoqdu vosndinusturilaSuoysliorn SRA snUsenounnsfievsan mnlaiivoyaunndray Abidudurtos uansdoyaMuusvanBarmuavermvaondeindn Mune Goumiueniuiliedeadqu UsedvBnw ennaandiy viaqumm (nsrdoulMorniuleduosd ninuAuenssuMso Ww suAEED) fiostoririoyoutiuiaiivanveutuusiaensd uelunsdlurdgluvy mrause tousls Wownuae 3Slde7 unnvinvern SRAS WMuanstoyaaituayulsedvsrmuaveravaondtertnsys (o) infuerdisingludlyfemdnuvend wWourautylsedytay Fosuans foyomatuerlulaiemanuin’ wouaigusediiy omiunulssavBomuavenavaants (om) shiuertbiiuer wie 0.0.0 (o) v3 (o) Aosuanstoyamsiteviotoya meiermsiialvayulsedvinmntornavaonie Jo.o ne ouriueunutlagdudniudasToyadruvseanBrmuasrnnacedty iudninustuavtioulstunrsiivrsan Al (@) srFunritiiaewaerd wy qUuvy uazrruussasatusriirunrsiuses dinnhusuAriuquaerdadivoniulucuseine wea wdanrsoyslineideus furs useinmiy 9 iloafuayurse@nSnrmuazarudaondvuedn uasuaneswasidun Summary of Product Characteristics Audutlaquu (o) ivowiMludnWonsvilanvoswuyyd FowuansswaxiSenvosedwane aqnvaweniivautianasluae (Maximum Residue Limit (MALs)) dif muelawmiausyy Codex Alimentarius w39 European Medicines Agency (EMA) wae Tolerances fifiimunlaumiausty U.S. Food and Drug Administration (USFDA) wa United States Department of Agriculture (USDA) (@) srFusihituenmuria 0.0.6 (a) via (o) dosuansioyanrsidentotoya nsiennnsfialuayulsednSmmronralaondie e.e.c ununisianrsanindusduquai Useinsam uaveraaoniie Iuvinnsdineidoutdueniiitefnatruquamn Useaniai uavaraaande dafoadoviruaumadansanmdussrinmationiy vsawuanadasusoanvsdaiiun sm muaunys Samsermidustae ilounrsiuvsetuhendendniiqunn Usedndaqw uavaraonsie uavil useluminnnherimndes we. eunulusudwsudad be mafiarmandoyarruqnunan Sngninntusetoulvtumsersan sed [Heya ronarsvfondng | waninnusfuneoulvlunstinsan nsauTinrsnane Hasuanansswisn sHamlavarduamuinanviasunus dunouusnnoanramnaudanrrussg uneuselinonndeatu gain ae a ae eet SorrmunannsgmuendfeqUuae | Tuenarsiodilodralouasiivatemed iene . Anwnuy (appearance) veserdniaqu b. nian aondnvalvosdndasiendasegy oeroviow Sasi anmaaoudnwuemamunm mredawuseandtuca div wivuiivutuuvul oo iatunaiionly a, VatmummargiumUzUuUuL (dosage form) vase? muditmueluehisierazguuntusen emdonavidatnan nnenssumsonmrsuaeu hime iu ergluvuvesuis rns uquauga uiiin odretoutosiinsmsaeaour iia aviuiu (Loss on drying) er7guuvuveaivar odraiautoria mrucasdrune eraudunsees ula <<. dosnmumnasgrunsudioudo gaurd uaetorinua anasgaumsUuoulanenin doatulumudswigguund seme Tnetérauqinunmuartormuenasgiy Witulu enumsreil o way bo HhumsrsilnssuTinranaiae nis OSD EI Li, Ee n ara Seas. FosuanansaaridmanainlauasSenmutnanatadumue Funowssnneamanfineudamauseg waeosmonndontiugnsen Porhmunnmaguerdusoquuay Bins ‘Imananstosilodinioutosiviatoned (@) dnweux (appearance) vasend sag (o) HBnrsasreiondhucivosnedeuviendaseyy odraviow Sosdimsnnaaoudnyawmanund asredaeusearmaucla din wivuvieutuuuue oo auntie (o) SattmuasnasgruAruguuvuT (dosage form) vase enuiitmunludiawriiguunsusenenianmidniney AusnTaUNsaIMauAvETMUA iy EIgUUUUVASUTS BAS equadga vrtia adrteutasiinismsaeaourwiinanh aviniu (Loss on drying) urguuvuveainar adraiioutoria prnuicaatanny erautunsadns udu (© tormumnmagumstutoudayauntd uaetorrun aneagumsUutoulansmnin deatulummshswisguued Usenan Tne Srququamunmuastoryunsnnsgyy Wbulu orumsreil 9 way vhemsrsil wniedofusowaniviasievinns a Uutlowiogauntd o. RoudumsusowmanrsienednsUutoutoyaunss atnation o qunaan wall doatumtsdeiuseswans Aunaawviornitasujdlins lunsdllanstinils daviolud (n) nswinereraninrsunnd wioquitneraiany nasuvn (a) HooujvanrsMlssunrssusaaninsgyw ISO/IEC 17025 wawwwaama ws (a) How {vinrsilAsunrssusosuimsguosdnys aunitelan (a) Hoag UAnrsvesanuananillarinsg run PIC/s GMP vdeo guanidu 9 maunsgiuidiiney pmusnyaumsonnsuasetusou to. nanvuarwvinuitautagaunid Kouuanunast annsgrumurseriiguuntusene a. Nidanwiarwimsvudoudoagauvdd bitulvan ar 7 pee dorinun Rowrdunrsarnunudanrsariudeshlaly Ariusadly,aoe Oreah aa arse o BWaruquaunrwuardorwmunwrmsgwunrsiansinrsudoutoqauniduae mavudoulanemnin Watonvmaaoy 3Bnvmaaou incusiirinagyu (Testing (Method) parameters) nasvudourda | shranagriuenmpilnslne wa, | swardunlumanel © unis eebo uavatuifiatay (Thai Herbal Pharmacopoeia 2017 and supplements) wiaatulvai oh nasvuidoulany | anmsgausriayulws 9.41, evo | (o) aramy (Arsenic) lau & dauludaudau wnin wavaturiaaa (Thai Herbal | (6) wanuiiea (Cadmium) bitfiu on daulu Pharmacopoeia 2017 and supplements) wieatulusinda vieiSnammaaavduitdninsay pusnssunasermasuacer huveu drudau (@) oui} (Lead) bifiu oo dauludqudew (@) Usem (Mercury) bitfiu o daulududay doviverunulusiuiiinaslidae rit dawlsenouveslavemindandrataadu ‘VWildiamemaeuaevaanalahauitmun ty Usemadatneuanenssunsensuace Gos vdninasinsfersantunsieutiy erunulumnfeaunasgumsuutou dogduviiduaclanemtin oaaneil Horrmunnnsgnugiuviddonagduvuer Sorhmunsnnagmugaundd Funumwvoniunid | dunuravondad Yuvidiame siulninetéomnn | user {Total Yeastand | (ecified microorganisms) (Total Aerobic | Mold Count (ry) pec! s quwuuen Microbial Count | (cfug wo efurmd TANCK v0 ful) quauusiulsemy fn esau doqiuaivietaiton: an. sa¥uerMUsenaund | hisnnnh @ x0" | Tainan €x @of | - wusaarwaitde Tela (Escherichia arsatin uaz/uiofie pe wat ve aqulws (fivioliitans Paras Uguss) dalinassusewr TudrwouwsMaeabuitan bi dJreedqunoliday maeuauntsaaniienansnan col) Wi binnni ao* cfu lu o nay ~ aiwuusaluuaa (Salmonetia spp.) lu lee ni - ivunaoaviiien (Clostridium spp) tuo ni |Sortmumnnagruqaunid Janumanoeyiadl | dnmurveosded quntdiawe Gtnstomnn | ase rota Yeastand | ep ecined microorganisms) {Totat Aerobie | Mold Count (TYMC) quuvuen Microbial Count | (cfg vo etwimd (TAMC)] (cfu/g wo cfu) 1. dndueriusenoudae | biannn € x @0* | binnniy «x @0° | - wuniiounsuautimab a (Bie- arsafin was/usone tolerant gram negative bacteria) wulé ayulus (Alvdoliistars ‘binnmh oo? dulu @ niu via @ Usui) uonuviiownn n, Sadie ~ bivtuuneunuaen (Salmonella spp) Woe niu via ee fiadaes | ~ hinuoawvotde Tala (Escherichia coli) tu @ niu Wi0 @ finan ainunaeaviiiten (Clostridium spp.) lu ni via o fiadains a. shiueniiiidaulseney | aannniiex | binnniae x | wuniifeunmeufimalé Bie vada wax/vFouisiq, @o* 0” tolerant gram negative bacteria) WU wduayulnsdaegy Suue VWhinannt @0” cfu lu @ nit nsdifiduarsdae Wer wie ofiadaina anulusiudrndudoitiu - binuusalauaan diulumunnusi n. via 9. (Salmonella spp.) lu ao ni udausinad via oofindains - linuroaiotidulata (Escherichia coli) lu @ n¥u vie o faadns - ‘iwuauailled ondaoaii ua (Staphylococaus aureus) tu @ 1331 via @ fieddns ~ Linurasavivten (Clostridium spp.) lu @ n¥u via oiladaios quuwuerlinwueniawieh fn. HaSuerqUuvUindy | bhranh w x00" | binant xoo” - yaanin ushiuuiifuionin | bannnine xc" | Linnie x ao | - linvaunillatondasadea sniueriltduaamds (Staphyococaus aureus) tu @ nu onuguuvugndseay) ia 0 fadesGor munanmagrugiundd Fernand | frum unidame téormm | uncr Tota Yeast and [Total Aerobic ‘Mold Count (TYMC)} (Specified microorganisms) quuuuen rob Count | (cle ve cum) (TAMCD] (cfu/g 0 efumd ar unnitttimeeyn ~uinvglaluuua wegétun shfuvitnvony (Pseudomonas aeruginosa) tu Nau v0 © Hiadiains -Limuraeaviivies: (Clostridium spp) Want vie oiedaes fa. enSuerguuuuuduuus | hisnnnd1 © xeo” | binnnintoxeo | - linuaunilatanAaaaiea fois (Staphylococcus aureus) lu @ ei - Lsinuglaluuua wegétuer (Pseucomonas aeruginosa) Wu usw ~ Linuraaariatiien (Clostridium spp) uo ui « iuergluuugmusemy ‘bhnamh ¢ x 0" | nnn &x eo - liwuaunillad anfasaiua (Staphylococcus aureus) lu « N34, = Linugleluuua uogatuer (Pseudomonas aeruginosa) tu 6 nd ~‘Linrunmoeviiiles Clostroum spp) wont exe maviersantoyadnudaeaniarmuacrriudaondy dadninasflunrsiersanoysyin weit wandausierunulunneudiniudnd lnevaludodundndeusiiiier des ananseld Foyovaeiinsld uasostnrajumnduulnontounudunadvayy lunsdiduertudauntoe nenadiusedosiinmumuuaifudoynod itussuuntodalsepuidernym ue menlnendo uauuifowrtoag (expert consensus) on UHUNIsTaNsATINaESm AUN UsvaveMW uazATUAaAsE uvrensdine dows iueriitotad aan UseanSaw uazerudaondy datos AorhunuMstanrsennavesinnrslioniy veFesuansdafusesnrsedunvsmaununrssanrs prudusiiae Hadunsiulsetwherandraiiqunw UseanBam uavarvaondy dasil Uselemannmer aides oo